BioPharma Dive's Top News

BROUGHT TO YOU BY — IBM Watson Health Reduced costs and a shorter lifecycle A CRO was able to reduce its full lifecycle cost by more than 50 percent and its clinical trial build time by 25 percent. Learn how

Note from the editor

We want you to tell us what you think.

Over the last five years, we've grown rapidly to provide you with essential journalism and in-depth insights into the biotech and pharma industries. But we think we can do better, too.

As the journalists behind BioPharma Dive, we want to know what you like about us, and what you think we can improve. That’s why we're asking you to please give us feedback in our first Reader Survey. You can take the survey right here.

We'll use your input to directly inform the journalism you see in this newsletter. Just a few minutes of your time will help us greatly.

Thanks for reading BioPharma Dive. We greatly appreciate your support.

Four steps to choosing the right CDMO partner In our webinar, hear from what industry experts believe are the four most important steps you can follow to assess and select the CDMO that fits your organization’s needs and aligns with your goals. Register Now

Best of What We're Reading

The Wall Street Journal Drug Giant Tries New Tactic to Fight Cancer

STAT Powerful new cancer drugs can trigger diabetes — and no one knows why

Xconomy Can Tiny Drug Doses (and One Woman's Fortune) Fight the Most Vicious Cancer?

The New York Times Scientists Wanted: Recruited by Juul, Many Researchers Say No

AP 6 months later, gene-edited babies stir new interest, debate

The Washington Post There's just one female physician in Congress. We talked to her.

Dive Into a Topic

Share BioPharma Dive with others and get rewarded. You've referred 0 readers. To become an official Dive Insider, just successfully refer 10 contacts to BioPharma Dive. Here's your link to share: https://www.biopharmadive.com/signup/insiders/?signup_referred_by=5a7c57efe9328b6b2a8b4587